Neuromuscular sarcopenia: what do we know?
The neuronal C-terminal agrin fragment must be established as a biomarker for neuromuscular sarcopenia, taking renal function into account as the fragment accumulates in renal insufficient patients. On this basis, treatment with agrin could be a therapeutic option for this subgroup of sarcopenia.
Authors
- Michael Drey (ORCID: https://orcid.org/0000-0001-6709-9672)
Institutions
- LMU Klinikum (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Current Opinion in Neurology
- Published
- 2025-05-16
- DOI
- https://doi.org/10.1097/wco.0000000000001373
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.00